Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7834 |
Intermediate Similarity |
NPD1380 |
Discovery |
0.7765 |
Intermediate Similarity |
NPD2544 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD1427 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD4239 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD1383 |
Phase 3 |
0.7688 |
Intermediate Similarity |
NPD1382 |
Phase 2 |
0.7557 |
Intermediate Similarity |
NPD8036 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD8037 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD9506 |
Approved |
0.7374 |
Intermediate Similarity |
NPD8408 |
Discontinued |
0.7363 |
Intermediate Similarity |
NPD8020 |
Approved |
0.7363 |
Intermediate Similarity |
NPD8021 |
Approved |
0.7303 |
Intermediate Similarity |
NPD8122 |
Approved |
0.7303 |
Intermediate Similarity |
NPD8123 |
Approved |
0.7284 |
Intermediate Similarity |
NPD2896 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD8063 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1352 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD3813 |
Approved |
0.7257 |
Intermediate Similarity |
NPD5862 |
Discovery |
0.7256 |
Intermediate Similarity |
NPD4805 |
Approved |
0.7246 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7246 |
Intermediate Similarity |
NPD4703 |
Approved |
0.7235 |
Intermediate Similarity |
NPD5358 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD2809 |
Approved |
0.7225 |
Intermediate Similarity |
NPD8026 |
Phase 1 |
0.7212 |
Intermediate Similarity |
NPD3717 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD5255 |
Approved |
0.7197 |
Intermediate Similarity |
NPD9284 |
Approved |
0.7195 |
Intermediate Similarity |
NPD1649 |
Discontinued |
0.7193 |
Intermediate Similarity |
NPD6026 |
Approved |
0.717 |
Intermediate Similarity |
NPD9207 |
Approved |
0.717 |
Intermediate Similarity |
NPD9206 |
Approved |
0.7168 |
Intermediate Similarity |
NPD2511 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1095 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD2582 |
Approved |
0.7151 |
Intermediate Similarity |
NPD2581 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4804 |
Approved |
0.7128 |
Intermediate Similarity |
NPD4427 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD5751 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD4174 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD6148 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD2012 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD8304 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD751 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7913 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD5088 |
Discontinued |
0.6989 |
Remote Similarity |
NPD6635 |
Approved |
0.6981 |
Remote Similarity |
NPD9080 |
Approved |
0.6973 |
Remote Similarity |
NPD3082 |
Discontinued |
0.697 |
Remote Similarity |
NPD203 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD4669 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD4670 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD4671 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD5352 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD1395 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD7469 |
Discontinued |
0.6878 |
Remote Similarity |
NPD4699 |
Discontinued |
0.6875 |
Remote Similarity |
NPD2118 |
Approved |
0.6875 |
Remote Similarity |
NPD2119 |
Approved |
0.6872 |
Remote Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD6872 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD1627 |
Clinical (unspecified phase) |
0.6862 |
Remote Similarity |
NPD4021 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD9382 |
Approved |
0.6857 |
Remote Similarity |
NPD9383 |
Approved |
0.6851 |
Remote Similarity |
NPD2076 |
Approved |
0.6851 |
Remote Similarity |
NPD2077 |
Approved |
0.6847 |
Remote Similarity |
NPD8327 |
Clinical (unspecified phase) |
0.6847 |
Remote Similarity |
NPD8325 |
Phase 3 |
0.6847 |
Remote Similarity |
NPD8326 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD1661 |
Suspended |
0.6821 |
Remote Similarity |
NPD3262 |
Approved |
0.6815 |
Remote Similarity |
NPD271 |
Approved |
0.6815 |
Remote Similarity |
NPD270 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD268 |
Approved |
0.6813 |
Remote Similarity |
NPD5322 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD4529 |
Approved |
0.6806 |
Remote Similarity |
NPD4528 |
Approved |
0.6806 |
Remote Similarity |
NPD4526 |
Approved |
0.6802 |
Remote Similarity |
NPD3576 |
Approved |
0.6802 |
Remote Similarity |
NPD7396 |
Approved |
0.6802 |
Remote Similarity |
NPD3575 |
Approved |
0.6791 |
Remote Similarity |
NPD6227 |
Discontinued |
0.6786 |
Remote Similarity |
NPD5486 |
Discontinued |
0.678 |
Remote Similarity |
NPD9398 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD687 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD4824 |
Approved |
0.6776 |
Remote Similarity |
NPD4823 |
Approved |
0.6748 |
Remote Similarity |
NPD3476 |
Approved |
0.6748 |
Remote Similarity |
NPD3475 |
Approved |
0.6739 |
Remote Similarity |
NPD1032 |
Phase 2 |
0.6727 |
Remote Similarity |
NPD3944 |
Approved |
0.6727 |
Remote Similarity |
NPD3942 |
Approved |
0.6717 |
Remote Similarity |
NPD7712 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD8321 |
Discontinued |
0.6707 |
Remote Similarity |
NPD9726 |
Discontinued |
0.6704 |
Remote Similarity |
NPD8129 |
Discovery |
0.6685 |
Remote Similarity |
NPD4639 |
Approved |
0.6685 |
Remote Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.6685 |
Remote Similarity |
NPD4638 |
Approved |
0.6685 |
Remote Similarity |
NPD4640 |
Approved |
0.6685 |
Remote Similarity |
NPD5100 |
Phase 3 |
0.6684 |
Remote Similarity |
NPD7233 |
Approved |
0.6684 |
Remote Similarity |
NPD7944 |
Discontinued |
0.6684 |
Remote Similarity |
NPD7234 |
Approved |
0.6683 |
Remote Similarity |
NPD5458 |
Discontinued |
0.6667 |
Remote Similarity |
NPD5541 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6569 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD820 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD748 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4375 |
Approved |
0.6667 |
Remote Similarity |
NPD1994 |
Approved |
0.6667 |
Remote Similarity |
NPD1995 |
Approved |
0.6667 |
Remote Similarity |
NPD6529 |
Discontinued |
0.6667 |
Remote Similarity |
NPD1993 |
Approved |
0.6649 |
Remote Similarity |
NPD4072 |
Approved |
0.6649 |
Remote Similarity |
NPD4071 |
Approved |
0.6649 |
Remote Similarity |
NPD3321 |
Discontinued |
0.6647 |
Remote Similarity |
NPD792 |
Discontinued |
0.6647 |
Remote Similarity |
NPD2089 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD269 |
Clinical (unspecified phase) |
0.6635 |
Remote Similarity |
NPD4086 |
Phase 1 |
0.6635 |
Remote Similarity |
NPD6298 |
Discontinued |
0.6633 |
Remote Similarity |
NPD31 |
Approved |
0.6633 |
Remote Similarity |
NPD4122 |
Approved |
0.6633 |
Remote Similarity |
NPD4037 |
Approved |
0.6633 |
Remote Similarity |
NPD4039 |
Approved |
0.6633 |
Remote Similarity |
NPD4034 |
Approved |
0.6633 |
Remote Similarity |
NPD4036 |
Approved |
0.6633 |
Remote Similarity |
NPD4033 |
Approved |
0.6633 |
Remote Similarity |
NPD4038 |
Approved |
0.6633 |
Remote Similarity |
NPD32 |
Approved |
0.6633 |
Remote Similarity |
NPD4035 |
Approved |
0.6632 |
Remote Similarity |
NPD4551 |
Phase 2 |
0.6627 |
Remote Similarity |
NPD4030 |
Approved |
0.6627 |
Remote Similarity |
NPD4029 |
Approved |
0.6627 |
Remote Similarity |
NPD4028 |
Approved |
0.6618 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.6615 |
Remote Similarity |
NPD6626 |
Approved |
0.6614 |
Remote Similarity |
NPD6241 |
Phase 1 |
0.6613 |
Remote Similarity |
NPD1620 |
Clinical (unspecified phase) |
0.6613 |
Remote Similarity |
NPD6555 |
Clinical (unspecified phase) |
0.6612 |
Remote Similarity |
NPD2123 |
Phase 3 |
0.6612 |
Remote Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD3525 |
Discontinued |
0.6605 |
Remote Similarity |
NPD9583 |
Approved |
0.66 |
Remote Similarity |
NPD6732 |
Clinical (unspecified phase) |
0.6597 |
Remote Similarity |
NPD6068 |
Discontinued |
0.6596 |
Remote Similarity |
NPD5596 |
Phase 2 |
0.6593 |
Remote Similarity |
NPD7287 |
Clinical (unspecified phase) |
0.6593 |
Remote Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD9357 |
Approved |
0.6579 |
Remote Similarity |
NPD3039 |
Clinical (unspecified phase) |
0.6578 |
Remote Similarity |
NPD6595 |
Phase 3 |
0.6567 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.6564 |
Remote Similarity |
NPD1598 |
Discontinued |
0.6564 |
Remote Similarity |
NPD992 |
Clinical (unspecified phase) |
0.6564 |
Remote Similarity |
NPD991 |
Phase 2 |
0.6561 |
Remote Similarity |
NPD1096 |
Discontinued |
0.6557 |
Remote Similarity |
NPD2619 |
Clinical (unspecified phase) |
0.6557 |
Remote Similarity |
NPD6553 |
Clinical (unspecified phase) |
0.6557 |
Remote Similarity |
NPD2620 |
Phase 2 |
0.6554 |
Remote Similarity |
NPD2061 |
Approved |
0.6545 |
Remote Similarity |
NPD1033 |
Clinical (unspecified phase) |
0.6545 |
Remote Similarity |
NPD1034 |
Phase 3 |
0.6545 |
Remote Similarity |
NPD715 |
Phase 3 |
0.6543 |
Remote Similarity |
NPD1783 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD3386 |
Phase 2 |
0.6543 |
Remote Similarity |
NPD7414 |
Clinical (unspecified phase) |
0.6542 |
Remote Similarity |
NPD8372 |
Clinical (unspecified phase) |
0.6541 |
Remote Similarity |
NPD2928 |
Phase 2 |
0.6538 |
Remote Similarity |
NPD5611 |
Phase 2 |
0.6534 |
Remote Similarity |
NPD510 |
Phase 1 |
0.6534 |
Remote Similarity |
NPD9706 |
Clinical (unspecified phase) |
0.6534 |
Remote Similarity |
NPD5965 |
Clinical (unspecified phase) |
0.6531 |
Remote Similarity |
NPD1622 |
Discontinued |
0.6531 |
Remote Similarity |
NPD1229 |
Phase 2 |
0.6531 |
Remote Similarity |
NPD2952 |
Discontinued |
0.6526 |
Remote Similarity |
NPD5555 |
Phase 1 |
0.6522 |
Remote Similarity |
NPD3116 |
Approved |
0.6522 |
Remote Similarity |
NPD3117 |
Approved |
0.6519 |
Remote Similarity |
NPD5925 |
Phase 1 |
0.6515 |
Remote Similarity |
NPD4396 |
Clinical (unspecified phase) |
0.651 |
Remote Similarity |
NPD6363 |
Clinical (unspecified phase) |
0.651 |
Remote Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.6509 |
Remote Similarity |
NPD201 |
Phase 2 |
0.6509 |
Remote Similarity |
NPD200 |
Phase 2 |
0.6495 |
Remote Similarity |
NPD6665 |
Discontinued |
0.6488 |
Remote Similarity |
NPD2141 |
Approved |
0.6488 |
Remote Similarity |
NPD2142 |
Approved |
0.6488 |
Remote Similarity |
NPD2140 |
Approved |
0.6485 |
Remote Similarity |
NPD1392 |
Approved |
0.6484 |
Remote Similarity |
NPD925 |
Approved |
0.6484 |
Remote Similarity |
NPD926 |
Approved |
0.6481 |
Remote Similarity |
NPD7558 |
Phase 2 |
0.648 |
Remote Similarity |
NPD7061 |
Clinical (unspecified phase) |
0.6468 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6468 |
Remote Similarity |
NPD8169 |
Discontinued |
0.6467
|
Remote Similarity |
NPD4973 |
Approved |